Lindsey van, OD
Optometrist · Lake Forest, CANPI 1811587892
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 73 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 19 manufacturers, the largest accounting for just 19.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $687, 8.0 times the $86 reported in 2021.
Across 73 payments — averaging $26.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$364
- Tarsus Pharmaceuticals, Inc.$221
- AbbVie$213
- Oyster Point Pharma, Inc.$205
- Sun Pharmaceutical Industries Inc.$183
- Alcon$171
- plus $550 from 13 others
What the payments were for
- Food & beverage$1,908100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 14 | $364 |
| Tarsus Pharmaceuticals, Inc. | 6 | $221 |
| AbbVie(2 entities) | 4 | $213 |
| Oyster Point Pharma, Inc. | 9 | $205 |
| Sun Pharmaceutical Industries Inc. | 7 | $183 |
| Alcon | 9 | $171 |
| Dompe US, Inc. | 5 | $115 |
| Novartis | 3 | $72 |
| Heru, Inc. | 1 | $66 |
| Coopervision Inc. | 3 | $56 |
| Johnson & Johnson Vision Care, Inc. | 2 | $53 |
| Mallinckrodt Hospital Products Inc. | 2 | $46 |
| Amgen | 2 | $34 |
| Harrow Eye, LLC | 1 | $27 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $22 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $17 |
| Biotissue Holdings Inc. | 1 | $15 |
| Rxsight Inc | 1 | $14 |
| Glaukos Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,908 in reported general payments places this provider in the 75th percentile of 6,778 optometrist providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 28 | $244 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Lake Forest
- Omid KhodaiLake Forest$499K
- Steve YoelinNewport Beach$4.1M
- Matthew GellerSpring Valley$3.5M
- Melissa EricksonDavis$522K
- Jason TuSan Diego$351K
- Scott SchachterPismo Beach$312K
- Alicia LauSan Diego$300K
- Vin DangBakersfield$284K
- Steven FerrucciSepulveda$272K
- Katie ChuRosemead$271K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.